VRPX - Virpax Pharmaceuticals, Inc.
0.6695
-0.551 -82.226%
Share volume: 2,782,368
Last Updated: 04-03-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.22
-0.55
-0.45%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-14-2024 | 03-03-2025 | |
| Assets | |||||
| Total Assets | 3.130 M | 2.591 M | 304.162 K | 1.556 M | |
| Current Assets | 3.130 M | 2.591 M | 304.162 K | 1.556 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.866 M | 1.871 M | 17.229 K | 1.513 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 3.130 M | 2.591 M | 304.162 K | 1.556 M | |
| Total liabilities | 4.344 M | 5.385 M | 2.356 M | 2.469 M | |
| Total current liabilities | 4.344 M | 5.385 M | 2.356 M | 2.469 M | |
| Accounts Payable | 1.844 M | 2.885 M | 2.356 M | 2.469 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.213 M | -2.794 M | -2.052 M | -913.760 K | |
| Common stock | 61.551 M | 63.420 M | 66.170 M | 70.698 M | |
| Retained earnings | -62.765 M | -66.215 M | -68.221 M | -71.611 M |